Episode 29 - The AI Revolution

This episode's guests: Chaim Linhart

This episode we are talking with Chaim Linhart, the Co-Founder and CTO of Ibex Medical Analytics

We will discover why Israel is such a hotbed of medtech start-ups. We will discuss the unique challenges and opportunities for unlocking the tools of digital pathology. We examine the differences between a strong AI and narrow AI and how strong AI can assist pathologists. Finally, we will look at how the IBEX solution will assist with cancer detection.


More About Chaim Linhart

Chaim Linhart, Co-Founder and CTO of Ibex Medical Analytics.

Chaim Linhart is the Co-Founder and CTO of Ibex Medical Analytics. Together with Co-Founder and CEO Joseph Mossel, he embarked on a journey to transform cancer diagnosis by empowering pathologists with AI insights that help them improve diagnostic accuracy, efficiency and turnaround times.

Chaim has over 25 years of experience in algorithm development, AI and machine learning at various roles including an elite technology unit in the Israel Defense Forces, academia, and several tech companies. Prior to founding Ibex, he was a senior researcher at TaKaDu, where he developed novel algorithms for identifying anomalies in data from sensors in water distribution networks. Before that, he was research manager at Sanctum, where he developed hacking techniques and defenses for web applications.

Dr. Linhart holds a PhD in Computer Science from Tel Aviv University. A prolific researcher in the fields of computational biology, pattern matching and computational geometry, he has published over 20 scientific papers, he is an inventor of multiple patents and winner of 3 Kaggle machine learning competitions.